Verastem (VSTM)
Add to Watchlists Create an Alert
9.29
+0.03 +0.32%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Verastem Shareholders Equity:
90.47M for Dec. 31, 2012Verastem Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 90.47M |
| Sept. 30, 2012 | 95.61M |
| June 30, 2012 | 102.37M |
| March 31, 2012 | 107.68M |
| Dec. 31, 2011 | -12.77M |
| Sept. 30, 2011 | 60.64M |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
VSTM Shareholders Equity Benchmarks
| Companies | |
|---|---|
| AVEO Pharmaceuticals | 141.18M |
| ARCA biopharma | 3.311M |
| Sangamo BioSciences | 64.90M |
VSTM Shareholders Equity Rankings
| Overall |
56th percentile 3334 of 7600 |
| Sector |
60th percentile 260 of 653 in Healthcare |
| Industry |
74th percentile 60 of 238 in Biotechnology |
VSTM Shareholders Equity Range, Past 5 Years
| Minimum | -12.77M | Dec 2011 |
| Maximum | 107.67M | Mar 2012 |
| Average | 74.00M |